Combination therapy with carboplatin and paclitaxel for small cell lung cancer

ConclusionA combination of carboplatin plus paclitaxel as second-line chemotherapy is effective and feasible in patients with SCLC, especially in those with ILD.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research